S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Argentina's populist president meets billionaire Elon Musk in Texas — and a bromance is born
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
It's almost April 15. Here's how to reduce stress and get your taxes done
Nearing 50 Supreme Court arguments in, lawyer Lisa Blatt keeps winning
How O.J. Simpson burned the Ford Bronco into America's collective memory
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Argentina's populist president meets billionaire Elon Musk in Texas — and a bromance is born
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
It's almost April 15. Here's how to reduce stress and get your taxes done
Nearing 50 Supreme Court arguments in, lawyer Lisa Blatt keeps winning
How O.J. Simpson burned the Ford Bronco into America's collective memory
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Argentina's populist president meets billionaire Elon Musk in Texas — and a bromance is born
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
It's almost April 15. Here's how to reduce stress and get your taxes done
Nearing 50 Supreme Court arguments in, lawyer Lisa Blatt keeps winning
How O.J. Simpson burned the Ford Bronco into America's collective memory
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Argentina's populist president meets billionaire Elon Musk in Texas — and a bromance is born
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
It's almost April 15. Here's how to reduce stress and get your taxes done
Nearing 50 Supreme Court arguments in, lawyer Lisa Blatt keeps winning
How O.J. Simpson burned the Ford Bronco into America's collective memory
NASDAQ:PRCT

PROCEPT BioRobotics (PRCT) Stock Price, News & Analysis

$50.71
-2.61 (-4.89%)
(As of 04/12/2024 ET)
Today's Range
$50.37
$52.92
50-Day Range
$45.73
$53.32
52-Week Range
$24.83
$54.50
Volume
419,507 shs
Average Volume
420,014 shs
Market Capitalization
$2.58 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$45.60

PROCEPT BioRobotics MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
10.1% Downside
$45.60 Price Target
Short Interest
Bearish
9.58% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.74mentions of PROCEPT BioRobotics in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$4.65 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($2.00) to ($1.50) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.61 out of 5 stars

Medical Sector

886th out of 923 stocks

Surgical & Medical Instruments Industry

91st out of 97 stocks

PRCT stock logo

About PROCEPT BioRobotics Stock (NASDAQ:PRCT)

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

PRCT Stock Price History

PRCT Stock News Headlines

My biggest AI fear
These 10 stocks have the power to make you a millionaire as early as 2026… And all you need is $10K. Investing in each of the stocks in The AI Millionaire Blueprint could make a 9,900% return in as little as the next three years.
PROCEPT BioRobotics (NASDAQ:PRCT) Trading 4.4% Higher
My biggest AI fear
These 10 stocks have the power to make you a millionaire as early as 2026… And all you need is $10K. Investing in each of the stocks in The AI Millionaire Blueprint could make a 9,900% return in as little as the next three years.
PRCT Oct 2024 55.000 call
PRCT Apr 2024 50.000 put
PRCT Jul 2024 70.000 call
PRCT Mar 2024 70.000 call
Q4 2023 Procept Biorobotics Corp Earnings Call
PROCEPT BioRobotics: Q4 Earnings Insights
See More Headlines
Receive PRCT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PROCEPT BioRobotics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/27/2024
Today
4/13/2024
Next Earnings (Confirmed)
5/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:PRCT
Fax
N/A
Employees
626
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$45.60
High Stock Price Target
$58.00
Low Stock Price Target
$37.00
Potential Upside/Downside
-10.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
6 Analysts

Profitability

Net Income
$-105,900,000.00
Pretax Margin
-77.76%

Debt

Sales & Book Value

Annual Sales
$136.19 million
Book Value
$5.56 per share

Miscellaneous

Free Float
40,975,000
Market Cap
$2.58 billion
Optionable
Optionable
Beta
1.01
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. Reza Zadno Ph.D. (Age 69)
    President, CEO & Director
    Comp: $1.26M
  • Mr. Kevin Waters (Age 47)
    Executive VP & CFO
    Comp: $744.1k
  • Ms. Alaleh Nouri (Age 45)
    EVP, Chief Legal Officer & Corporate Secretary
    Comp: $713.61k
  • Mr. Hisham Shiblaq (Age 48)
    Executive VP & Chief Commercial Officer
    Comp: $757.2k
  • Mr. Mohan F. Sancheti (Age 60)
    Senior Vice President of Operations
  • Mr. Barry Templin
    Executive VP of Technology & Clinical Development
  • Mr. Matthew James Bacso C.F.A.
    Vice President of Investor Relations
  • Ms. Stacey L. Porter (Age 48)
    Chief People Officer
  • Mr. Bijesh Chandran
    Senior Vice President of Regulatory Affairs & Quality Assurance

PRCT Stock Analysis - Frequently Asked Questions

Should I buy or sell PROCEPT BioRobotics stock right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for PROCEPT BioRobotics in the last twelve months. There are currently 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" PRCT shares.
View PRCT analyst ratings
or view top-rated stocks.

What is PROCEPT BioRobotics' stock price target for 2024?

6 brokerages have issued 12 month price objectives for PROCEPT BioRobotics' shares. Their PRCT share price targets range from $37.00 to $58.00. On average, they expect the company's stock price to reach $45.60 in the next twelve months. This suggests that the stock has a possible downside of 10.1%.
View analysts price targets for PRCT
or view top-rated stocks among Wall Street analysts.

How have PRCT shares performed in 2024?

PROCEPT BioRobotics' stock was trading at $41.91 at the beginning of 2024. Since then, PRCT stock has increased by 21.0% and is now trading at $50.71.
View the best growth stocks for 2024 here
.

When is PROCEPT BioRobotics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our PRCT earnings forecast
.

How can I listen to PROCEPT BioRobotics' earnings call?

PROCEPT BioRobotics will be holding an earnings conference call on Wednesday, May 1st at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were PROCEPT BioRobotics' earnings last quarter?

PROCEPT BioRobotics Co. (NASDAQ:PRCT) posted its quarterly earnings data on Tuesday, February, 27th. The company reported ($0.54) EPS for the quarter, missing the consensus estimate of ($0.44) by $0.10. The firm had revenue of $43.58 million for the quarter, compared to analysts' expectations of $41.79 million. PROCEPT BioRobotics had a negative trailing twelve-month return on equity of 46.59% and a negative net margin of 77.75%. The company's revenue was up 83.3% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.56) earnings per share.

What ETFs hold PROCEPT BioRobotics' stock?
What guidance has PROCEPT BioRobotics issued on next quarter's earnings?

PROCEPT BioRobotics updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $210.0 million-$210.0 million, compared to the consensus revenue estimate of $204.5 million.

When did PROCEPT BioRobotics IPO?

PROCEPT BioRobotics (PRCT) raised $126 million in an initial public offering on Wednesday, September 15th 2021. The company issued 5,500,000 shares at $22.00-$24.00 per share.

How do I buy shares of PROCEPT BioRobotics?

Shares of PRCT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PRCT) was last updated on 4/13/2024 by MarketBeat.com Staff

From Our Partners